Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer.
Kinehara Y, Minami T, Kijima T, Hoshino S, Morimura O, Otsuka T, Hayama Y, Fukushima K, Takeuchi Y, Higashiguchi M, Miyake K, Hirata H, Nagatomo I, Inoue K, Takeda Y, Kida H, Kumanogoh A.
Kinehara Y, et al. Among authors: kijima t.
Lung Cancer. 2015 Mar;87(3):321-5. doi: 10.1016/j.lungcan.2015.01.003. Epub 2015 Jan 10.
Lung Cancer. 2015.
PMID: 25601188